Common Stock, Shares, Outstanding of BioNexus Gene Lab Corp from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BioNexus Gene Lab Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • BioNexus Gene Lab Corp Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 1,796,597, a 90% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BioNexus Gene Lab Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,796,597 -16,171,066 -90% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 1,796,597 -15,871,066 -90% 30 Jun 2025 10-Q 18 Aug 2025 2025 Q2
Q1 2025 17,967,663 +300,000 +1.7% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 1,796,766 -15,870,897 -90% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 17,967,663 +175,000 +0.98% 30 Sep 2024 10-Q 15 Nov 2024 2024 Q3
Q2 2024 17,667,663 -156,050,489 -90% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 17,667,663 -156,050,489 -90% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 17,667,663 +3,191,150 +22% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 17,792,663 -155,925,489 -90% 30 Sep 2023 10-Q/A 26 Mar 2024 2023 Q3
Q2 2023 173,718,152 +2,500,000 +1.5% 30 Jun 2023 10-Q 16 Aug 2023 2023 Q2
Q1 2023 173,718,152 +2,500,000 +1.5% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 14,476,513 -156,741,639 -92% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 173,718,152 +2,500,000 +1.5% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 171,218,152 0 0% 30 Jun 2022 10-Q 16 Aug 2023 2023 Q2
Q1 2022 171,218,152 0 0% 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 171,218,152 0 0% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 171,218,152 +68,487,261 +67% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 171,218,152 +68,487,261 +67% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 171,218,152 0 0% 31 Mar 2021 10-Q 18 May 2021 2021 Q1
Q4 2020 171,218,152 +68,487,261 +67% 31 Dec 2020 10-K 06 Apr 2022 2021 FY
Q3 2020 102,730,891 +29,033,333 +39% 30 Sep 2020 10-Q/A 09 Nov 2020 2020 Q3
Q2 2020 102,730,891 +28,103,333 +38% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 171,218,152 31 Mar 2020 10-Q 18 May 2021 2021 Q1
Q4 2019 102,730,891 +28,103,333 +38% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 73,697,558 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 74,627,558 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q4 2018 74,627,558 31 Dec 2018 10-K 31 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.